(1) How was this issue identified? Starting in quarter 1 2007, we noticed the high rate of excess dosing for heparin on our ACTION site reports compared to national rates. (2) What did you do to ...
Heparin injectable solution only comes as a generic drug. It doesn’t have a brand-name version. Heparin comes in two forms. One is an injectable solution, which you inject under your skin. The other ...
Critical pathways exist in many hospitals for treating patients with a suspected or confirmed diagnosis of venous thromboembolism (VTE). Some pathways call for “baseline laboratory studies,” including ...
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
Heparin remains a cornerstone of anticoagulation therapy in diverse clinical settings, from intensive care units to cardiac surgery and thromboprophylaxis. Unfractionated heparin (UFH) and low ...
Monitoring unfractionated heparin (UFH) using the activated partial thromboplastin time (APTT) or the anti-factor Xa (anti-Xa) chromogenic assay still seems to be a controversy. Is the anti-Xa less ...
This webinar will look at the principles of the assays available to monitor heparin. The most frequent assay that is used is the activated partial thromboplastin time (aPTT). This assay is readily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results